Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, announced new data from a large aortic dissection artificial intelligence real-world study that supports the use of its artificial intelligence technology for...
Strides Pharma Science Ltd on Friday said its Singapore-based arm has received approval from the US health regulator for generic potassium chloride oral solution, used to treat or prevent low amounts of potassium in the blood. The approval granted...
Microvi, a transformative biology company based in the San Francisco Bay Area, announced that it has been awarded over $1.1 million in funding from the National Institute of Health (NIH) to scale-up its newly developed technology to eliminate ....
In this article, we have focused on recent innovations in the biopharmaceutical sector that has the potential to change pharmaceutical drug development.
With more than 70 million diabetic patients, India is known as the diabetes capital of the world. On top of that, the country is on its way to reach 200 million pre-diabetics as well. Driven by the increasing number of diabetes patients in the cou...
Aurobindo Pharma Ltd on said it has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing facility at Pydibhimavaram in Andhra Pradesh. The company's Unit XI at Pydibhimavaram is an API...
Biotheus Inc., a clinical-stage biotech company focused on the discovery and development of biologics for oncology and inflammatory diseases, announced that they have entered into a collaboration agreement with Hansoh Pharmaceuticals, for Biotheus'..
Biocon said on Tuesday that its Biocon Biologics subsidiary has secured all the regulatory approvals for the acquisition of Viatris' biosimilar business and is in the process of completing an $800 million equity infusion as part of the deal...
SK Biopharmaceuticals, a global innovative pharmaceutical company, announced that the state-run Korea Drug Development Fund (KDDF) has decided to support and finance the company's development of SKL27969, which is being evaluated as potential...
HitGen Inc. announced that it has entered into a research collaboration agreement with Daewoong Pharmaceutical Co., Ltd (“Daewoongâ€), a global healthcare group in the Republic of Korea, dedicated to improving the quality of patients' lives. HitGen...
, CDSCO.jpg)
